You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HPV negative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Head-and-neck Squamous-cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma Trial (Ficlatuzumab,

Not yet recruiting
  • Metastatic Head-and-neck Squamous-cell Carcinoma
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • Ficlatuzumab
  • +2 more
  • (no location specified)
Sep 26, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

HPV-Related Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Oral Cavity, Squamous Cell Carcinoma of the Larynx Trial in

Not yet recruiting
  • HPV-Related Squamous Cell Carcinoma
  • +4 more
  • Cleveland, Ohio
    University Hospitals Cleveland Medical Center, Case Comprehensiv
Jan 31, 2023

Sinonasal Cancer, Squamous NSCLC, Lung Cancer Trial run by the National Cancer Institute (NCI) (pembrolizumab, valemetostat)

Not yet recruiting
  • Sinonasal Cancer
  • +5 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 5, 2023

HPV-Negative Squamous Cell Carcinoma Trial in Chicago (Paclitaxel, Carboplatin, Cetuximab)

Not yet recruiting
  • HPV-Negative Squamous Cell Carcinoma
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Aug 16, 2023

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

Recruiting
  • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
Feb 9, 2023

Epigenetic Silencing of MicroRNA for Predicting Therapeutic

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Not interventional
  • Albuquerque, New Mexico
    University of New Mexico - Cancer Center
Oct 4, 2022

Head Neck Cancer, Head Neck Cancer Trial in Saint Louis (Pyrimethamine)

Not yet recruiting
  • Head and Neck Cancer
  • Cancer of the Head and Neck
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 4, 2023

Head and Neck Squamous Cell Carcinoma Trial in Brescia (Niraparib)

Recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Brescia, Italy
    Asst Degli Spedali Civili Di Brescia
Aug 3, 2022

Squamous Cell Carcinoma of Head and Neck, Neoadjuvant Therapy, Resection Margin Trial in Wuhan (Reducing Excision Margins)

Active, not recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +2 more
  • Reducing Excision Margins
  • Wuhan, Hubei, China
    Zhanjie Zhang
Jul 11, 2022

Human Papilloma Virus, Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Head and Neck Trial in Chicago (Carboplatin,

Recruiting
  • Human Papilloma Virus
  • +4 more
  • Chicago, Illinois
    University Of Chicago Medicine Comprehensive Cancer Center
Jun 3, 2022

Head and Neck Early Relapse Detection Study (HERD)

Not yet recruiting
  • Head and Neck Cancer
    • (no location specified)
    Jul 28, 2022

    HNSCC Trial in Tucson (Abemaciclib)

    Recruiting
    • HNSCC
    • Tucson, Arizona
      University of Arizona
    Mar 3, 2022

    Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

    Active, not recruiting
    • Laryngeal Cancer Stage II
    • +3 more
    • Amsterdam, Netherlands
      The Netherlands Cancer Institute
    Sep 27, 2022

    Head and Neck Squamous Cell Carcinoma Trial in New Haven (5-Azacitadine)

    Completed
    • Head and Neck Squamous Cell Carcinoma
    • New Haven, Connecticut
      Smilow Cancer Center at Yale New Haven Hospital
    Feb 3, 2022

    Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Human Papillomavirus-Related Carcinoma, Locally

    Recruiting
    • Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +5 more
    • Liposomal HPV-16 E6/E7 Multipeptide Vaccine PDS0101
    • Pembrolizumab
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Squamous Cell Head and Neck Carcinoma Trial (Durvalumab, radiotherapy, Placebo)

    Withdrawn
    • Squamous Cell Head and Neck Carcinoma
    • (no location specified)
    May 6, 2021

    Blood Tests and Questionnaires in Studying Adherence to

    Recruiting
    • Carcinoma of Unknown Primary
    • +30 more
    • Biospecimen Collection
    • Questionnaire Administration
    • Houston, Texas
      M D Anderson Cancer Center
    Dec 12, 2022

    Anal High Grade Squamous Intraepithelial Lesion, Anal Precancerous Condition, AIN 2/3 Trial in San Francisco, Chicago, New York

    Not yet recruiting
    • Anal High Grade Squamous Intraepithelial Lesion
    • +5 more
    • San Francisco, California
    • +2 more
    Nov 7, 2022

    Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx Trial in Philadelphia

    Active, not recruiting
    • Stage III, IVa, or IVb Squamous Cell Carcinoma of the Oral Cavity, Oropharynx, Larynx, or Hypopharynx
    • Nelfinavir (Viracept®) 1250 mg
    • FMISO
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Jun 30, 2021

    Human Immunodeficiency Virus, Human Papillomavirus- 6, 11, 16, 18, Adolescent Trial run by the NCI (Gardasil, Survey)

    Completed
    • Human Immunodeficiency Virus
    • +3 more
    • Gardasil
    • Survey
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 26, 2022

    Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)

    Active, not recruiting
    • Head and Neck Squamous Cell Carcinoma
    • Saint Louis, Missouri
      Washington University School of Medicine
    Feb 25, 2022

    Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage IV

    Recruiting
    • Clinical Stage III Human Papillomavirus (HPV)-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
    • +28 more
    • San Francisco, California
      University of California, San Francisco
    Dec 16, 2022

    Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma, Clinical Stage III HPV-Mediated (p16-pos) Oropharyngeal

    Not yet recruiting
    • Clinical Stage II HPV-Mediated (p16-pos) Oropharyngeal Carcinoma
    • +15 more
    • Best Practice
    • +9 more
    • Scottsdale, Arizona
      Mayo Clinic in Arizona
    Aug 23, 2022

    Primary Cervical Cancer Screening by Self-sampling HPV Test

    Recruiting
    • Human Papillomavirus Infection
    • +16 more
      • Beijing, Beijing, China
      • +5 more
      Jan 12, 2023